References
- Andriol (testosterone undecanoate capsules) product monograph, Merck Canada inc. Drug Product Database, Health Canada (2012). www.hc-sc.gc.ca/dhp-mps/prodpharma/databasdon/index_e.html.
- Yin AY , HtunM, SwerdloffRSet al. Re-examination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self- emulsifying formulation. J. Androl.33, 190–122 (2011).
- Bagchus WM , HustR, MarisF, SchnabelPG, HouwingNS. Important effect of food on the bioavailability of oral testosterone undecanoate. Pharmacotherapy23(3), 319–325 (2003).
- Morgentaler A , DobsA, KaufmanJ, MinerM, ShabsighR, SwerdloffR, WangC. Long lasting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study. J. Urol.180, 2307–2313 (2008).
- Qoubaitary A , MeriggiolaC, MingCet al. Pharmacokinetics of testosterone undecanoate injected alone or in combination with norethisterone enanthate in healthy men. J. Androl.27(6), 853–867 (2006).
- Roth M , DudleyR, HullLet al. Steady-state pharmacokinetics of oral testosterone undecanoate with concomitant inhibition of 5a-reductase by finasteride. Int. J. Androl.34, 541–547 (2010).
- Schnabel P , BagchusW, LassH, ThomsenT, GeurtsP. The effect of food composition on serum testosterone levels after oral administration of Andriol® Testocaps®. Clin. Endocrinol.66, 579–585 (2007).
- Shackleford DM , FaassenWA, HouwingNet al. Contribution of lymphatically trans- ported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs. J. Pharmacol. Exp. Ther.306, 925–933 (2003).
- Wang C , ShiraishiS, LeungAet al. Validation of a testosterone and dihydrotestosterone liquid chromatography tandem mass spectrometry assay: interference and comparison with established methods. Steroids73(13), 1345–1352 (2008).
- Nq BH , YuenKH. Determination of plasma testosterone using a simple liquid chromatographic method. J. Chromatogr. B793(2), 421–426 (2003).
- Baba S , FujiokaM, ShinoharaY, FurutaT. Determination of testosterone propionate in human plasma by gas chromatography-mass spectrometry. J. Chromatogr.337(2), 205–212 (1985).
- FDA . FDA backgrounder for Sept. 18, 2014 advisory committee meeting for clarus therapeutics NDA 206089, 101–104 (2014). www.fda.gov/AdvisoryCommittees/ucm406131.htm.
- EMA Guideline on Bioanalytical Method Validation February 2012 (2012). www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.
- Food and Drug Administration Draft Guidance for Industry . Bioanalytical method validation (2013). www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm368107.pdf.